PATENT CLAIM ANALYSIS

Application Number: 15574944
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to the preparation of a medicinal agent comprising DNAzymes according to Seq. ID 2-62 for the prophylaxis and treatment of virus infections that are caused by picornaviruses, in particular by rhinoviruses, in particular for the prophylaxis and treatment of rhinitis, head colds, asthma, COPD and viral infections of the upper respiratory tract.

Claim (Index 1):
An agent for the prophylaxis and treatment of a viral infection caused by a picornavirus, the agent comprising at least one DNAzyme of the type 10-23 selected from SEQ ID NOS: 2-62, wherein the DNAzyme comprises at least one catalytic domain, a substrate binding domain I, and a substrate binding domain II, the substrate binding domains I and II being at least 80% complementary to a target sequence of an mRNA of the picornavirus.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 88.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13741895', '11544926', '13230340', '14757293', '08316384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6920964722973507
- 35 USC 102 Novelty (BERT): 0.5094738634064336
- Combined Prediction Score: 0.6738342114082589
- Mean Citation Score: 209.214612
- Max Citation Score: 244.16992
- Similarity Product: 165.2610888115501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test